Source: Eur Respir J 2013; 41: 115-122
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bouvry Diane, Mouthon Luc, Brillet Pierre-Yves, Kambouchner Marianne, Ducroix Jean-Pierre, Cottin Vincent, Haroche Julien, Viallard Jean-Francois, Lazor Romain, Lebargy François, Tazi Abdellatif, Wallaert Benoît, Smail Amar, Pellegrin Jean-Luc, Nunes Hilario, Amoura Zahir, Cordier Jean-François, Valeyre Dominique, Naccache Jean-Marc, the Groupe Sarcoïdose Francophone. Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis. Eur Respir J 2013; 41: 115-122

Member's Comments

No comment yet.

Related content which might interest you: Humoral immunodeficiency and the lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=220 Year: 2005 Pulmonary diseases in primary immunodeficiency syndromes Source: Respipedia Article Year: 2017 Lung involvement in common variable immunodeficiency (CVID): a case series Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 A case of lymphoid interstitial pneumonia associated with common variable immunodeficiency Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 How could we objectively measure lung disease severity in children with severe combined immunodeficiency? Source: Annual Congress 2005 - New insights in respiratory infections in children Year: 2005 Interstitial lung disease in common variable immunodeficiency associated granulomatous disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 A HRCT score to differentiate between structural and interstitial lung disease in children with common variable immunodeficiency (CVID) Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010 Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease Source: Eur Respir J 2005; 25: 570-573 Year: 2005 Cavitary lung masses in SLE patients: an unusual manifestation of CMV infection Source: Eur Respir J 2004; 24: 182-184 Year: 2004 Comparison of health status in stable patients with bronchiectasis due to common variable immune deficiency (CVID), and idiopathic bronchiectasis Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011 Association between congenital pulmonary disease and primary immunodeficiency in the bronchiectasis patients Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Source: Eur Respir J 2011; 38: 384-391 Year: 2011 Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients Source: Eur Respir J 2002; 20: 28S-39S Year: 2002 Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry Source: Eur Respir J 2001; 18: Suppl. 33, 510s Year: 2001 Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome Source: Eur Respir J 2003 Oct 01;22(4):709-711 Year: 2003 AIDS and pulmonary tuberculosis (PTB): radiological and bacteriological spectrum in correlation with CD4 lymphocyte count Source: Annual Congress 2006 - Epidemiology and control of tuberculosis Year: 2006 HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis Source: Eur Respir J 2011; 38: 1151-1157 Year: 2011 Sarcoidosis, a systemic disease Source: Annual Congress 2005 - Sarcoidosis: update on extrathoracic organ problems Year: 2005 Herpesvirus type 1-8 in BAL fluid from HIV-1-infected patients with suspected pneumonia and from healthy individuals Source: Eur Respir J 2001; 18: 146-150 Year: 2001 Interstitial lung disease in CVID (GLILD): clinical presentation and comparison to CVID without ILD Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019